HAS2 is responsible for the synthesis of hyaluronan (HA), a glycosaminoglycan with a demonstrated role in cancer initiation and progression and whose elevated accumulation in either the stroma or tumour parenchyma of many cancers is linked to tumour aggressiveness and poor outcome [67, 68]. Here, HAS2 is linked to cancer.